Related Experiment Videos
Bright artificial light produces subsensitivity to clonidine.
1Department of Psychiatry, College of Medicine, Ohio State University, Columbus 43201-1228.
Life Sciences
|January 1, 1988
Summary
Chronic bright light exposure may reduce the body's response to clonidine, an alpha 2-agonist. This suggests potential changes in alpha 2-receptor sensitivity following light therapy.
Area of Science:
- Neuroscience
- Pharmacology
- Chronobiology
Background:
- Alpha 2-adrenergic receptors play a role in regulating body temperature.
- Somatic treatments for depression, including light therapy, may influence neurotransmitter systems.
Purpose of the Study:
- To investigate if chronic bright artificial light treatment leads to subsensitivity to clonidine's hypothermic effects.
- To explore the impact of light exposure on alpha 2-receptor function.
Main Methods:
- Utilized a thermoregulation paradigm to assess physiological responses.
- Administered clonidine, an alpha 2-agonist, after a one-week bright light treatment protocol.
Main Results:
- One week of bright light treatment significantly blunted the hypothermic response to clonidine (p < 0.00001).
- Demonstrated a statistically significant reduction in the body's temperature decrease after clonidine administration.
Conclusions:
- Chronic bright light exposure induces subsensitivity to the hypothermic effects of clonidine.
- Findings support the hypothesis that light therapy may alter alpha 2-receptor sensitivity, similar to other somatic depression treatments.